Day: December 16, 2024

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) — Sony Honda Mobility Inc. (SHM) announced today that they have partnered with Stingray Group Inc. (TSX: RAY.A; RAY.B), a leading music, media and technology company, to expand its in-car entertainment services. Through this partnership, AFEELA customers will be able to use Stingray Karaoke and enjoy in-car karaoke services. With the introduction of Stingray Karaoke, customers will have access to a massive international song library of over 100,000 licensed tracks. This collection browsable by title, artist, lyrics, or genre, features today’s top charting artists and yesterday’s legends. It spans a wide range of genres, including Pop, Rock, Country, Rap, R&B, K-Pop, Holiday Classics and Kids & Family, providing AFEELA customers with an enhanced entertainment experience for every...

NEWTOWN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) — Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced a partnership with Databricks, the data and AI company, to deliver access to its Chartis™ product, which maps physician and organization affiliations, through Databricks Marketplace. This collaboration will empower healthcare organizations with enhanced visibility into Forian’s robust information products, driving innovative solutions in healthcare research, drug development and patient care. Using Forian’s proprietary scoring algorithm, Chartis™ is designed to uncover and track valuable provider connections to enhance decision-making across the healthcare ecosystem. Employing an innovative...

The Franklin by LGI HomesThe Franklin features a spacious, open-concept layout floor plan and beautiful exterior stone detailing.WAYNESBORO, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce the grand opening of Brimington Farm, a brand-new community in Waynesboro, Pennsylvania. This affordable, upgraded community offers homebuyers the opportunity to purchase a newly built home with built-in upgrades at a price that makes homeownership attainable. Brimington Farm offers modern homes in a charming, established neighborhood. Homebuyers can choose from 3-bedroom townhomes starting in the $300s or 3- to 4-bedroom single-family homes starting in the mid-$400s. Each home comes with LGI Homes’ CompleteHome Plus™ package, including granite countertops,...

SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here. (https://register.vevent.com/register/BI0dce2f02ed2f44c8901127623aa788c3) Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN. To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com . Replay: A replay of the call will be available for one year via webcast...

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to announce the successful implementation of KorrAI Technologies Inc.’s (“KorrAI“) advanced analysis at the Company’s Nut Lake Project (the “Project“). KorrAI’s hyperspectral imaging and AI-driven analysis continue to play a critical role in enhancing the efficiency and precision of future exploration efforts, leading to actionable targets and advancing Greenridge’s objectives. The Company received significant outcomes, which were achieved through this innovative program with KorrAI (the “Program“). The 2024 exploration program included seventeen (17) sample locations that showed readings greater than 30,000 cps, with...

Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with treatment-refractory NSCLC expressing wild-type KRAS (wtKRAS) One-year OS was 58% for patients with NSCLC expressing mKRAS versus 23% for wtKRAS Mec-V antitumor activity observed across 9 different mKRAS variants Strong association of AXL expression by mKRAS NSCLC confirmed SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, presented a poster entitled “Characterization of Mutated KRAS Genotype and Clinical Outcomes in Patients With Advanced NSCLC...

A Landmark Year of Growth, New Leadership, and Strategic Advancements for Ladybug Nutratech TULSA, Okla., Dec. 16, 2024 (GLOBE NEWSWIRE) — Ladybug Resource Group, Inc. (“Ladybug”) (OTC PINK: LBRG), operating as Ladybug Nutratech, proudly announces a remarkable milestone in its history, surpassing $9.6 million USD in revenue for the nine months ending September 30, 2024. This achievement represents a significant increase of approximately $7.5 million compared to total revenues generated in 2023. This monumental growth underscores Ladybug’s steadfast commitment to innovation, strategic market positioning, and sustainable value creation for shareholders. “This year has been a defining moment for our company,” stated a member of the Board of Directors. “We are delivering on our promise to expand market...

– Dose-finding clinical trial in China designed to evaluate safety and preliminary anti-tumor activity of SN301A (SENTI-301A manufactured in China) in hepatocellular carcinoma (“HCC”) – SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that the first patient has been dosed in the pilot trial of SN301A in HCC in mainland China in collaboration with Celest Therapeutics (Shanghai) Co. Ltd (“Celest”). SN301A utilizes the anti-GPC3 + crIL-15 (each as defined below) SENTI-301A Gene Circuit developed by Senti Bio and refers to the chimeric antigen receptor natural killer (“CAR-NK”) product candidate manufactured by Celest...

Core Analysis Highlights Key Geological Features Supporting Hydrogen Storage Potential at Robinsons River Salt Project VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) (“Vortex” or the “Company”) is pleased to announce the completion of core logging and preliminary analysis of samples from Well VW231, part of the Robinsons River Salt Project (“The Project”) in Newfoundland. This study was conducted in collaboration with Dr. Hassan Dehghanpour and his research team at the University of Alberta under an NSERC Alliance research partnership, the findings highlight the geological suitability of the site for underground hydrogen storage (UHS). The primary objective of the study was to evaluate the feasibility and safety of using the salt dome within the Robinsons River...

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent potentially best-in-class customized vectors and transformative genetic medicines Proprietary intravitreal vector R100 demonstrated superior transduction and transgene expression compared to AAV2, the standard AAV serotypes used in retinal gene therapies, in all three human retinal cell types evaluated in vitro (up to ~10-fold improvement), and in all primate retinal cell layers after intravitreal injection in vivo Intravitreal administration of the R100 vector-based 4D-150 genetic medicine in nonhuman primate wet AMD model was well tolerated, led to robust retinal expression of dual transgenes (aflibercept and anti-VEGF C) and complete suppression of severe CNV choroidal neovascularization lesions 4D-150...